TOWNSEND RICHARD NOLAN (Chief Executive Officer) sold 0.9% of their position (3.35K shares) of LEXEO THERAPEUTICS, INC. on the open market
Open‑market sale worth $16.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/19/2026ACC: 0001995218-26-000015
DirectorOfficer· Chief Executive Officer
Since Feb 2026
-3.35K
Net shares
Net seller
$16.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.35K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.35K
Price / share
$4.95
Trade value
$16.56K
% of position
0.9%
8/18/2026
377.82K→374.47K
Total
Net shares
−3.35K
Net value
-$16.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/18/2026 | S · Sale | −3.35K | $4.95 | $16.56K | 0.9% | 377.82K | 374.47K |
| Total | −3.35K | -$16.56K | ||||||
Derivative Transactions0
No derivative transactions reported